Abstract:Bis(7)-tacrine was evaluated for efficacy on memory retention in mice 17 days of age and 30 days of age. The tests used were a passive-avoidance response test and a measure of spontaneous motor activity. Also, possible drug-induced hepatotoxicity and acute drug toxicity were evaluated. Behavioral studies were performed using a step-through task and an open-field test with a 24-h interval between training and evaluation tests. Bis(7)-tacrine (0.06-20 micromol/kg) was subcutaneously injected 30 min prior to the first session of both test types. During the training session of the step-through task, bis(7)-tacrine treatment reduced (by 46%, P<0.01) the number of avoidable electric shocks (footshocks) only at a high dose of 20 micromol/kg in mice 17 days of age, but dose-dependently decreased the number of footshocks (10-56%, P<0.001) in mice 30 days of age. Bis(7)-tacrine treatment at all doses tested did not produce any detectable changes in retention latency in mice 17 days of age, but the drug significantly prolonged retention latency at low doses (1.25 and 2.50 micromol/kg), and not high doses (5-20 micromol/kg), in mice 30 days of age. In the open-field test, bis(7)-tacrine decreased spontaneous motor activity in the acquisition session only at a high dose of 20 micromol/kg in mice 17 days of age and 30 days of age (by 28 and 45%, respectively), but did not affect spontaneous motor activity in the recall session. Bis(7)-tacrine treatment at a dose of 20 micromol/kg produced a more potent hepatotoxic effect in mice 30 days of age than in mice 17 days of age, (P<0.05), and the drug caused acute toxicity with comparable potencies in mice of both age groups. In conclusion, mice 30 days of age seemed to be more sensitive than mice 17 days of age to bis(7)-tacrine-induced cognitive function enhancement and hepatotoxicity. Bis(7)-tacrine appears to be more potent and more selective as a cognitive function-enhancing agent than tacrine.

Bis(7)-tacrine, a Novel Acetylcholinesterase Inhibitor, Reverses AF64A-induced Deficits in Navigational Memory in Rats.

Attenuation of Scopolamine-Induced Deficits in Navigational Memory Performance in Rats by Bis(7)-Tacrine, a Novel Dimeric AChE Inhibitor.

Effects of Bis(7)-Tacrine, A Novel Anti-Alzheimer'S Agent, on Rat Brain Ache

Bis (7)-Tacrine Ameliorates Cognitive Impairment Caused by Cerebral Hypoperfusion in Rats

Bis(7)-Tacrine, a promising anti-Alzheimer's agent, attenuates glutamate-induced cell injury in primary cultured cerebrocortical neurons of rats

Bis(7)-tacrine, a Promising Anti-Alzheimer's Dimer, Affords Dose- and Time-Dependent Neuroprotection Against Transient Focal Cerebral Ischemia

Mechanism of bis(7)-tacrine inhibition of GABA-activated current in cultured rat hippocampal neurons

Reversal of Scopolamine-Induced Spatial and Recognition Memory Deficits in Mice by Novel Multifunctional Dimers Bis-Cognitins

Bis(7)-tacrine, a novel dimeric AChE inhibitor, is a potent GABA(A) receptor antagonist

Huperzine A Ameliorates the Spatial Working Memory Impairments Induced by AF64A.

[Effects of TAK-147, a Novel Acetylcholinesterase Inhibitor, on Spatial Memory Deficit As Evaluated by Morris Water Maze of Rats]

Tacrine Accelerates Spatial Long-Term Memory Via Improving Impaired Neural Oscillations and Modulating GAD Isomers Including Neuro-Receptors in the Hippocampus of APP/PS1 AD Mice

Effect of bis(7)-tacrine on cognition in rats with chronic cerebral ischemia.

Inhibition of NMDA-gated ion channels by bis(7)-tacrine: whole-cell and single-channel studies

Effect of 3-[1-(phenylmethyl)-4-piperidinyl]-1-(2,3,4,5-tetrahydro-1h-1-benzazepin-8-yl)-1-propanone Fumarate, a Novel Acetylcholinesterase Inhibitor, on Spatial Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion in Rats

Bis(7)‐tacrine Attenuates Β Amyloid‐induced Neuronal Apoptosis by Regulating L‐type Calcium Channels

Evaluation of acute bis(7)-tacrine treatment on behavioral functions in 17-day-old and 30-day-old mice, with attention to drug toxicity.

A Tacrine-Tetrahydroquinoline Heterodimer Potently Inhibits Acetylcholinesterase Activity and Enhances Neurotransmission in Mice.

East meets West in the search for Alzheimer's therapeutics - novel dimeric inhibitors from tacrine and huperzine A.

Reversal of Scopolamine-Induced Spatial Memory Deficits in Rats by TAK-147.

Bis(7)-tacrine, a promising anti-Alzheimer's agent, reduces hydrogen peroxide-induced injury in rat pheochromocytoma cells: comparison with tacrine.